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Simian T cell leukemia virus (STLV)-1, the simian counterpart of HTLV-1, naturally infects Old World monkeys and shares virologic, immunological, molecular, and pathological features with HTLV-1 [13] [14] [15] . Phylogenic relationships of most virus subtypes indicate that STLV-1 is the simian ancestor of HTLV-1 that resulted from cross-species transmission from multiple nonhuman primates (NHP) to humans [16] [17] [18] [19] [20] . In naturally infected monkeys, STLV-1 pathogenesis is similar to HTLV-1 in humans, causing ATLL-like pathological features in a minority of individuals after a long period of latency [21] [22] [23] [24] .
HTLV-1 infection was demonstrated in several monkey species inoculated with MT-2 cells, Ra-1 cells, or autologous HTLV-1-infected cell lines [25, 26] . Rhesus macaques and squirrel monkeys have been successfully infected with HTLV-1 and used as NHP models for studying HTLV-1 pathogenesis, drug testing, and vaccine trials [27] [28] [29] [30] [31] [32] .
The current study employed the rhesus model to test the hypothesis that HIV/HTLV-1 coinfection is associated with increased HTLV-1 expression and disease. Rhesus macaques were infected with a primary clinical isolate of HTLV-1 from an individual with associated clinical diseases, TSP/HAM and polymyositis [27] . These macaques were then either simultaneously or serially coinfected with a pathogenic simian immunodeficiency virus (SIV) [33, 34] . Macaques were followed longitudinally for HTLV-1 by culture, polymerase chain reaction (PCR), serologic, and flow cytometry testing to assess virological and immunological responses and for hematological parameters to assess ATLL cell emergence in the circulation.
MATERIALS AND METHODS

Macaques. Seven Chinese rhesus macaques (Macaca mulatta;
6 males and 1 female) were used. Macaques were 1-2 years old and confirmed seronegative and PCR negative for STLV-1 and SIV at the study initiation. Three Indian and 3 Chinese rhesus macaques from earlier studies served as SIV-monoinfected controls (L.N.M., unpublished data) [35] . Naturally STLV-1-infected macaques were also utilized as controls for baseline values.
All animal housing, care, and research were performed in conformance with the Guide for the Care and Use of Laboratory Animals (National Research Council) and the guidelines at the Tulane National Primate Research Center, were fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, and were in accordance with Animal Welfare Act guidelines. Protocols were approved by the Institutional Animal Care and Use Committee. Physical exams were performed either biweekly or monthly, and macaques were provided full supportive care. Moribund macaques were humanely killed, and necropsies were performed.
Viruses. A CD4 + HTLV-1-producing cell line, denoted "HTLV KT ," was used for inoculum preparation. HTLV KT was established from cultured peripheral blood mononuclear cells (PBMCs) of a patient with TSP/HAM, polymyositis, uveitis, and lymphoid interstitial pneumonitis [36] . The inoculum was shown to be free of HIV and Mycoplasma by culture and PCR. Macaques were inoculated intravenously (iv) once or twice with ∼ phytohemagluttin-stimulated autologus PBMCs co- 7 1 ϫ 10 cultured with irradiated HTLV-1 KT cells, as described 6 5 ϫ 10 elsewhere [27] (figure 1). After 1-2 years of HTLV-1 infection, subjects P574, P671, M744, P442, and P111 were iv inoculated with 50-100 TCID 50 of freshly thawed, cell-free, cryopreserved stock of SIVsmB670. Macaque N365 was simultaneously iv inoculated with both PBMC/HTLV-1 KT coculture and cell-free SIVsmB670. An additional control, rhesus N401, was mock inoculated with autologous PBMCs and later inoculated with the HTLV-1 KT PBMC coculture, as described above.
Clinical testing, viral detection, and serologic analysis. Routine monthly clinical testing included complete blood counts, differential white blood cell (WBC) counts, chemistry levels, and parasite stool examination. Additional blood was collected for virologic, serologic, and flow cytometric evaluations. PBMCs were isolated from blood by density Ficoll-Hypaque separation, for both culture and cryopreservation for storage and later nucleic acid extraction and PCR.
HTLV-1 p19 antigen detection in PBMC culture, serologic analysis, genomic DNA isolation, and end-point PCR of circulating PBMC genomic DNA were performed as described elsewhere [27] . Culture supernatants were harvested at days 7, 14, and 21 for HTLV-1 viral p19 antigen detection, by use of a commercial kit (Zeptometrix). A positive culture was defined as antigen detection at any of the times points tested. Serologic assays were performed using a commercial ELISA kit (Abbott Laboratories). Serial 2-fold dilutions of serum (1:20-1:1280) were assayed in accordance with the manufacturer's instructions. A spectrophotometric reading of у2.5 times the optical density reading of a serum sample from an uninfected control macaque was obtained as a positive titer.
Plasma samples for SIV RNA viral antigen analysis were cryopreserved at Ϫ70ЊC until analysis. SIV antigenemia was determined by SIV p27 core antigen ELISA (Beckman Coulter) in accordance with the manufacturer's instructions.
Virus load quantification. Real-time PCR quantification was performed with the Prism 7700 sequence detection system (Applied Biosystems ABI) for HTLV-1tax and RNase P amplification. Primers were as follows: HTLV tax, forward primer 7930F, 5 -GCC CTA ATA ATT CTA CCC GAA GAC T-3 ; reverse primer 8040R, 5 -GGT TGA GTG GAA CGG AAG GA-3 ; and probe 7991P, 5 -Reporter dye-FAM-CCG TCA CGC TAA CAG CCT GGC A-3 -TAMRA-Quencher. Primers were selected according to parameters defined by the Primer Express software (version 2.0; ABI) and were based on strain J02029 [37] . Plasmid pMT2 containing the full HTLV-1 tax/rex coding region in pUC13 was used as HTLV-1 control DNA to generate the standard curve [38] . Fifty-microliter reactions contained 1 ϫ 10 1 -copies of viral control DNA or 500 ng of genomic , and P442 (P111 data not shown). Each virus inoculum is shown with the virus name boxed and positioned above the inoculation date, which is shown in months after initial human T cell leukemia virus (HTLV) type 1 inoculation. Inoculation with HTLV-1 is shown for M744, P574, P671, and P442. These same macaques were later inoculated with the second virus, simian immunodeficiency virus (SIV). One macaque (N365) was simultaneously inoculated with HTLV-1 and SIV. N401, originally the uninfected control, received a mock infection initially. After 20 months, N401 was inoculated with HTLV-1 and used as the single HTLV-1-infected control for the coinfection experiments. Antibody response to HTLV-1 was tested by EIA, and resultant titers are shown longitudinally by columns. The presence of HTLV-1 p19 in peripheral blood mononuclear cell culture is shown as + or Ϫ below each of the monthly culture points.
min at 50ЊC, 10 min at 95ЊC, and 40 cycles of 15 s at 95ЊC and 60 s at 60ЊC. Viral copy numbers were interpolated from the plasmid control regression curve. Finally, RNase P, a singlecopy gene (2 copies/diploid cell) was used as an endogenous DNA reference to accurately quantify cell equivalents and normalize sample variability. RNase P primers, probe, and standards were commercially obtained (ABI). Final HTLV-1 proviral copy number was calculated for each sample as follows: HTLV-1 copies/[RNase P copies/ cells). The lower monoclonal antibody staining and flow cytometry, as described elsewhere [34] . CD2 + T cells and CD20 + B cells were identified with anti-T11 and anti-B1 (Beckman Coulter). CD4 + T cells, CD8 + T cells, and CD25 + T cells were identified with anti-CD4 (clone L200), anti-CD8 (clone RPA T8), and anti-CD25 (clone 2A3) (BD Biosciences). Erythrocytes were lysed, and leukocytes were fixed with ImmunoPrep reagents using the TQ-Prep System (Beckman Coulter). Data acquisition and analysis were performed on a FACSCalibur device using Cell Quest software (BD Biosciences). Absolute numbers of cells were determined by calculating the percentage of the subset multiplied by total lymphocytes.
Enumeration of "flower cells." Giemsa-stained peripheral blood smears were prepared, 100 WBCs were counted, lineage was assessed, and smears were analyzed for the presence of the abnormally lobulated flower cell lymphocytes of HTLV infection [39] . Mean numbers of flower cells in the HTLV/SIV group compared with those in the controls were analyzed using an independent t test with unequal variances assumed to 3 months. Multiple comparisons required P values to be adjusted using the Bonferroni correction factor.
To control for spontaneous occurrence of flower cells in uninfected or single virus-infected NHP and to establish baselines, blood smear slides from previously tested SIV and STLV-1-negative or singly STLV-1-positive colony macaques were evaluated. As a control for accuracy, an independent investigator reading and quantification of flower cells was performed on a blinded sample set including smears from both viruspositive and -negative macaques. Readings had a high correlation (96%) between investigators.
RESULTS
Rhesus macaques were inoculated with HTLV-1 KT -infected cells and SIVsmB670 to study the virological, immunological, and clinical effects of dual retroviral infection. Five macaques (P671, P574, P442, P111, and N401) were initially singly inoculated with HTLV-1 (figure 1). Two macaques from a previous study were also utilized: M744, inoculated with HTLV-1 only; and N365, inoculated with HTLV-1 simultaneously with SIV [27] . Five persistently HTLV-1-infected macaques (M744, P574, P671, P111, and P442) were later inoculated with 50-100 TCID 50 of SIVsmB670 and monitored along with N365, the other dually HTLV-1/SIV-infected macaque. SIV infection was confirmed in all coinfected macaques by positive SIV p27 antigen in the circulation (data not shown). Macaque N401 remained as an singly HTLV-1-infected control.
Progression to AIDS was observed at 3-13 months in 5 of 6 the serially coinfected macaques and at 28 months in the simultaneously coinfected macaque, N365. These macaques died of colitis, cachexia, dyspnea, lymphoid hyperplasia, and opportunistic infections, typical for terminal immunodefi- ciency disease. Macaque P442 did not show clinical signs of AIDS. For this macaque, however, an elected necropsy 5 months after SIV coinfection showed severe lymphoid hyperplasia in both lymph nodes and spleen.
After HTLV-1 inoculation, longitudinal samples for all 7 macaques confirmed HTLV-1 infection by antigen detection in PBMC culture, serologic analysis, and end-point PCR. Figure  1 depicts these culture and serologic results for 6 of the 7 macaques (excluding P111). HTLV p19 antigens were detected in PBMC cultures for 6 of the inoculated macaques. HTLVp19 antigen in cultures were positive before or during peak antibody production with differences in peak responses cor- in P574 and N401. P111 with intermittent positive culture and PCR results never mounted a detectable antibody response (data not shown). Macaque P442, with high antibody response, was culture negative for 12 years. N401 antibody decrease was associated with intermittent positive cultures. P574, P671, M744, and P442 cultures decreased to undetectable levels, despite persistence of infection as documented by PCR (data not shown). After SIV inoculation, HTLV-1 antibody levels were reduced further and were correlated with positive HTLV p19 detection in cultures in all coinfected macaques.
After SIV coinfection, HTLV loads were monitored and quantified by real-time PCR amplification of the HTLV-1 tax gene. At baseline, HTLV-1 tax was either undetectable (M744, P574, P442, and N365) or low (P671 and P111), with only 37.8 and 36.3 provirus copies/ PBMCs (figure 2). After 6 1 ϫ 10 SIVsmB670 inoculation, distinct increases were documented in 4 macaques by 2 weeks, progressing to peak levels over 1 to several months. Peak levels of HTLV provirus were as follows: P111, 83 copies/ PBMCs (1 month); P574, 367 copies/ 6 1 ϫ 10 PBMCs (1.5 months); P671, 156 copies/ PBMCs 6 6 1 ϫ 10 1 ϫ 10 (2 months); and M744, 68 copies/ PBMCs (2 months). 6 1 ϫ 10 N365, simultaneously HTLV-1/SIV coinfected, was more delayed, with provirus emerging at 4 months after infection and progressing to a peak of 164 copies/ PBMCs at 5 months. 6 1 ϫ 10 Macaque P442 remained completely negative by PCR for HTLV-1 KT sequences in PBMCs throughout the entire time of monitoring.
T cell subset population changes after SIV infection were evaluated by flow cytometry. Three Indian and 3 Chinese rhesus from earlier studies were used as historical controls for singly SIV-infected macaques. These SIV-positive macaques showed CD2 + T lymphocytes ranging from 1000 to 3100 cells/mm 3 , CD8 + T lymphocytes ranging from 500 to 1900 cells/mm 3 , and CD4 + T lymphocytes decreasing to only a few hundred cells per cubic millimeter within 1 year (L.N.M., unpublished data) [34] . No sharp increases in either CD2 + or CD8 + T cell populations were noted after SIV monoinfection.
Baseline CD2 + T lymphocytes in the study macaques ranged from 1230 to 3262 cells/mm 3 ] at 1 month), which then decreased to 1173 and 803 cells/mm 3 , respectively. These data collectively suggest that dual HTLV/SIV coinfections cause a distinct but transient CD2 + CD8 + T cell lymphocytosis. The CD25 + T cell surface marker (interleukin-2 receptor a chain) has long been known to be activated and present on HTLV-1-infected and transformed ATLL cells [40, 41] . To evaluate increases after SIV coinfection, CD25 + T lymphocytes in 4 of the macaques (P574, P671, P111, and P442) were monitored by flow cytometry. CD25 + cells at baseline for 4 macaques ranged from 110 to 164 cells/mm 3 and then progressively decreased to very low levels (18- ). The flower n p 16 cells observed in the study HTLV-1-positive control, N401, ranged from 0% to 3% and averaged 1.3%. The coinfected macaques-M744, P574, P671, P111, and P442-showed dramatic increases in flower cells to 7%, 8%, 10%, 6%, and 12% during the first 3 months (figure 4) (M744 not shown). N365, the macaque concurrently inoculated with HTLV-1 and SIV, showed varying levels of flower cells (0%-6%) during the first 2 years after infection, which increased to 19% in a period of 5 months before progression to AIDS and death the following month (data not shown). Figure 6 shows the calculated means of flower cells for the coinfected macaques compared with the control for 10 months after SIV inoculation. t test analysis of flower cells in HTLV-1/SIV-coinfected macaques ( ) through 3 months after infection were shown to be n p 6 significantly higher ( ) than those observed in the P p .001 HTLV-1-positive control macaque (
) and indicate stan p 1 tistical significance, compared with the Bonferroni-adjusted critical value of . P p .007
DISCUSSION
This study showed that SIV coinfection of HTLV-1-infected rhesus monkeys up-regulated HTLV-1 expression and emergence of flower cells in the peripheral circulation. Although the small numbers of macaques in the study precludes powerful statistical analysis, clear changes were documented. After SIV coinfection, specific increases in HTLV-1 p19, HTLV proviral loads, circulating CD2 + CD8 + T cells, and abnormal flower cells were clearly evident. The increased occurrence of у3% of flower cells in the circulation of coinfected macaques was significantly higher than in the control, yet the macaques maintained normal WBC counts. These findings are consistent with the pattern seen in chronic and smoldering forms of adult T cell leukemia/lymphoma [39, 42] . Furthermore, peripheral blood smears of healthy carriers of HTLV-1 rarely if ever show 11% flower cells [43] . The emergence of flower cells in all 6 coinfected macaques during infection also suggests the possibility that HTLV and SIV may increase the risk for development of leukemia and lymphoma in dually infected individuals.
It has been reported that HIV appears to increase the risk for HTLV-1-associated disease, including hematologic malignancies and TSP/HAM [8, 10, 44] . The dynamics of HIV and HTLV coinfections remain unclear, but Beilke et al. [9] showed that coinfections are associated with increased HTLV-1 mRNA in PBMCs. HIV/HTLV coinfections pose diagnostic and prognostic problems for physicians who do not routinely test their HIV-infected patients for HTLV-1 or HTLV-1I antibodies.
HIV/HTLV-1 coinfections are often associated with sustained periods of normal or even elevated CD4 + T cell counts [45] and early neurologic complications in the face of normal CD4 + T cell counts [12] . CD4 + /CD25 + T cells, specifically the T regulatory (T reg ) cell subpopulation, are suggested as the major reservoir for HTLV-1, express virus, down-regulate the normal suppressor function, allow expansion of HTLV-1 tax-specific CD8 + T cells, and contribute to viral pathogenesis [ 46, 47] . In addition, CD8 + CD25 + T cells have been shown to be a viral reservoir in vivo and involved in pathogenesis of HTLV-1-mediated disorders [46] [47] [48] .
This study clearly supports clinical observations in humans that HIV/HTLV-1 coinfection may up-regulate cell proliferation, HTLV-1 expression, and increase disease potential. After SIV coinfection, CD4 + CD25 + cells progressively decreased, with only 2 of 4 macaques showing intermittent and transient increases over the course of terminal decrease. SIV-specific CD4 + T reg cell depletion is a possible cause for this sharp decrease in CD4 + CD25 + T cells [49] . Elimination of the T reg cell suppressor function by SIV and resultant immune hyperactivation [49] along with HTLV-1-induced spontaneous lymphoproliferation may also explain the subsequent increases in the CD8 + CD25 + T cell subpopulation and the increase in HTLV replication that were documented in the macaques [46, 47] . The emergence of large numbers of flower cells in macaques, resembling those seen in the circulation of patients with ATLL, is particularly striking. The flower cells directly correlated with CD8 + /CD25 + T cells and suggested the possible involvement of this subpopulation in disease progression. Additional studies are ongoing to assess this correlation. Fultz et al. [50] obtained similar results in pig-tailed macaques inoculated with SIV-PBj and STLV-I. During 2 years of follow-up of singly and dually infected macaques, no differences in SIV burdens, onset of disease, or survival were detected. However, in the first coinfected macaque that died of AIDS (1 year after infection), 150% of CD4 + and CD8 + T lymphocytes expressed CD25, and lymph nodes showed a monomorphic population of lymphoblastoid cells. The authors suggested a preleukemic condition due to STLV/SIV coinfection and speculated that SIV may have potentiated STLV-related disease.
The exact mechanism of up-regulated HTLV-1 expression after SIV coinfection cannot be determined through the current studies. However, the possibility exists that flower cells would continue to increase along with T lymphocyte population decrease after SIV infection. This would suggest that loss of immune control, as opposed to immune stimulation, would be a possible mechanism to explain up-regulation of HTLV-1. This is further evidenced by the late increase in HTLV-1 p19 viral antigen detection in PBMC cultures after a decrease in HTLV-1 antibody titers.
Taken together, our results suggest that the SIV/HTLV-1 model of coinfection may be useful for further studies of HTLV-1 leukemogenesis. The model may also prove very useful in testing the efficacy of antiretroviral compounds and antineoplastic agents for the treatment of HTLV-1 disease manifestations.
